STERIS plc (STE)
NYSE Market Closed
STERIS plc is a medical technology and services company focused on infection prevention, contamination control and sterilization. Although domiciled in Ireland, the company has major operations in the United States and serves healthcare providers, medical device manufacturers, pharmaceutical companies and research organizations around the world.
STERIS is especially significant in contract sterilization, where it helps medical device makers prepare single-use instruments, implants and other healthcare products for safe use. Its Applied Sterilization Technologies business operates facilities that use validated sterilization methods for customers that require strict regulatory compliance and high reliability. This makes STERIS an important partner in the global supply chain for sterile medical products.
The company also sells equipment, consumables and services used inside hospitals and other care settings. Its products include sterilizers, washer-disinfectors, surgical table and operating room equipment, endoscopy-related reprocessing products and infection prevention supplies. These offerings support central sterile departments, operating rooms and other areas where cleaning, disinfection and sterilization are essential to patient safety.
In life sciences, STERIS provides contamination control products and services for biopharmaceutical manufacturing, laboratories and other regulated environments. Its customer base benefits from recurring demand driven by procedure volumes, regulatory standards, outsourced sterilization needs and the ongoing requirement to prevent healthcare-associated infections.
STERIS stands out for its combination of equipment, consumables, services and outsourced sterilization capacity. That mix gives the company exposure to healthcare delivery, medical technology production and biopharma manufacturing rather than relying on a single product category.
Last updated
- Market Cap
- $21,230,181,011
- P/E
- 27.13
- P/FCF
- 21.83
- P/S
- 3.58
- Enterprise Value
- $22,722,281,011
- Sector
- Health Care
- Industry
- Health Care Equipment
- Address
- 70 SIR JOHN ROGERSON'S QUAY, DUBLIN, L2, 2
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $21,230,181,011
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $22,722,281,011
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 27.13
- P/B
P/B ratio compares a company's share price to its book value per share.
- 2.96
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.58
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 14.27
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.83
- EPS
- 8.03
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 1.14%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 21.83
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 15.83
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $972,400,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 10.89%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 7.29%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.27
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.09
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.54
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.38
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $839,999
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 217.84
Income Statement
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Revenue | 1.59B | 1.5B | 1.46B | 1.39B | 1.48B |
| Cost of revenue | 891.2M | 840.7M | 814.4M | 763.1M | 839.3M |
| Gross profit | 697.2M | 655.5M | 645.9M | 628M | 641.2M |
| Operating income | 316.9M | 273.3M | 265.8M | 246M | 216.2M |
| EBITDA | 440M | 395.7M | 389.7M | 367.2M | 353.8M |
| Net income | 220.2M | 192.9M | 191.9M | 177.4M | 145.6M |
| Income taxes | 84.2M | 63.5M | 60.6M | 53.9M | 50.5M |
| Interest expense | -15.1M | -14.9M | -14.9M | -15.9M | -17.2M |
| Other operating expenses | -300K | 400K | 2.2M | 1.8M | 63.5M |
| Total operating expenses | 380.3M | 382.2M | 380.1M | 382M | 425M |
| Basic EPS | 2.25 | 1.96 | 1.95 | 1.8 | 1.49 |
| Diluted EPS | 2.24 | 1.96 | 1.94 | 1.79 | 1.47 |
Balance Sheet
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Total assets | 10.74B | 10.59B | 10.41B | 10.41B | 10.15B |
| Total liabilities | 3.54B | 3.42B | 3.39B | 3.44B | 3.53B |
| Total equity | 7.2B | 7.17B | 7.02B | 6.97B | 6.62B |
| Cash & equivalents | 439.6M | 423.7M | 319.2M | 279.7M | 171.7M |
| Current assets | 2.39B | 2.29B | 2.11B | 2.06B | 2B |
| Current liabilities | 1.15B | 922.3M | 888.9M | 926.6M | 1.02B |
| Accounts payable | 338.8M | 285.1M | 308.9M | 300.9M | 280.8M |
| Receivables | 1.09B | 990.6M | 947.3M | 947.1M | 1.04B |
| Inventories | 631.8M | 673.5M | 658.5M | 641.2M | 581.3M |
| Goodwill | 4.19B | 4.23B | 4.22B | 4.22B | 4.1B |
| Long-term debt | 1.81B | 1.9B | 1.9B | 1.9B | 1.92B |
Cash Flow
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | 335.5M | 298.2M | 287.7M | 420M | 260.9M |
| Investing cash flow | -217.3M | -98.4M | -88.4M | -108.5M | -69.7M |
| Financing cash flow | -97.8M | -98.1M | -159.2M | -213.1M | -178M |
| Change in cash | 15.9M | 104.5M | 39.5M | 108M | 16.5M |
| Net income | 220.3M | 194.4M | 192.4M | 178M | 146.1M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — STERIS plc | View Filing | |
| form 4 | Form 4 — Sohi Mohsen | View Filing | |
| form 4 | Form 4 — Sohi Mohsen | View Filing | |
| form 4 | Form 4 — Sohi Mohsen | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 11-K — STERIS plc | View Filing | |
| edgar index | 144 — STERIS plc | View Filing | |
| form 4 | Form 4 — Zangerle John Adam | View Filing | |
| edgar index | DEF 14A — STERIS plc | View Filing | |
| edgar index | DEFA14A — STERIS plc | View Filing | |
| edgar index | ARS — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 144 — STERIS plc | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 144 — STERIS plc | View Filing | |
| form 4 | Form 4 — Burton Karen L | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| form 4 | Form 4 — Fraser Mary Clare | View Filing | |
| form 4 | Form 4 — Kohler Kenneth E | View Filing | |
| form 4 | Form 4 — Madsen Julia | View Filing | |
| form 4 | Form 4 — Tamaro Renato | View Filing | |
| form 4 | Form 4 — Zangerle John Adam | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| edgar index | 4 — STERIS plc | View Filing | |
| form 4 | Form 4 — Burton Karen L | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| form 4 | Form 4 — Fraser Mary Clare | View Filing | |
| form 4 | Form 4 — Kohler Kenneth E | View Filing | |
| form 4 | Form 4 — Madsen Julia | View Filing | |
| form 4 | Form 4 — Tamaro Renato | View Filing | |
| form 4 | Form 4 — Zangerle John Adam | View Filing | |
| edgar index | 144 — STERIS plc | View Filing | |
| form 4 | Form 4 — Breeden Richard C | View Filing | |
| form 4 | Form 4 — Breeden Richard C | View Filing | |
| form 4 | Form 4 — Breeden Richard C | View Filing | |
| form 4 | Form 4 — Breeden Richard C | View Filing | |
| form 4 | Form 4 — Boulud Pierre | View Filing | |
| form 4 | Form 4 — Burton Karen L | View Filing | |
| form 4 | Form 4 — Burton Karen L | View Filing | |
| form 4 | Form 4 — Burton Karen L | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing | |
| form 4 | Form 4 — Carestio Daniel A | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free